Synektik S.A. Logo

Synektik S.A.

Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synektik S.A. is a provider and integrator of innovative solutions for the medical sector, with a focus on radiology, oncology, cardiology, and neurology. The company's core operations include the manufacturing of radiopharmaceuticals, the supply and service of advanced medical equipment, and the development of specialized IT solutions. Synektik supports medical facilities with products and services used in diagnostic imaging, nuclear medicine, and surgery, aiming to implement and disseminate modern medical technologies. The company also provides comprehensive maintenance for medical devices and IT infrastructure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 08:39
Regulatory News Service
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 4 kw. 2024
Polish 1.3 MB
2025-11-18 08:39
Regulatory News Service
wybrane dane finansowe za 4 kw. 2024
Polish 204.6 KB
2025-10-28 09:40
Report Publication Announcement
Terminy publikacji raportów okresowych - Content (PL)
Polish 2.0 KB
2025-10-27 15:29
Major Shareholding Notification
Zawiadomienie
Polish 83.0 KB
2025-10-27 15:29
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej - zmiana …
Polish 1.7 KB
2025-10-27 12:52
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-23 12:37
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-21 08:51
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-20 10:43
Regulatory News Service
Temat: Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - C…
Polish 1.8 KB
2025-10-14 14:39
Related Party Transaction
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-10-09 09:16
Regulatory News Service
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - C…
Polish 1.4 KB
2025-09-29 13:34
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.7 KB
2025-09-23 14:05
Board/Management Information
życiorys nowego Członka Zarządu
Polish 92.3 KB
2025-09-23 14:05
Board/Management Information
Powołanie nowego Członka Zarządu - Content (PL)
Polish 1.2 KB
2025-09-16 16:47
Related Party Transaction
Uzupełnienie informacji o zawarciu istotnej umowy sprzedaży systemu robotyczneg…
Polish 1.3 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synektik S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea
217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden
KARO
Karyopharm Therapeutics Inc. Logo
Develops novel oral cancer therapies by inhibiting nuclear export for hard-to-treat tumors.
United States of America
KPTI
KAZIA THERAPEUTICS LTD Logo
Oncology-focused drug development firm advancing anti-cancer candidates for brain cancers in trials.
United States of America
KZIA
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea
038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea
256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan
4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland
KNRS
Kiniksa Pharmaceuticals International, plc Logo
Develops and commercializes immune-modulating therapies for debilitating diseases with unmet needs.
United States of America
KNSA
KIORA PHARMACEUTICALS INC Logo
Developing advanced small molecule therapies for vision-threatening retinal diseases.
United States of America
KPRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.